PillRx only · Injection, Solution · Intramuscular
Gentamicin
Gentamicin Sulfate
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.368
Latest avg · Jul 22, 2026
-18%
Since Dec 17, 2025
4
Active US suppliers
67%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
888
Rx · 2026 Q1
23K
Units dispensed
-4%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi USA, LLC | unknown | 3 | SUPPLYING |
| Eugia US LLC | unknown | 3 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 2 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- May 29, 2025RECALLRecall (Class II): Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India f…
Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis. — Recalling firm: Eugia US LLC — Nationwide in the USA